BioElectronics Executive Vice President Dr. Deepak Kotak Interviewed on CEOLive.TV – Explains the Changing Paradigm of Chronic Pain

FREDERICK, MD, USA, February 9, 2015 — BioElectronics Corporation (OTC: BIEL), the maker of an industry leading family of bioelectric pain therapy devices, said today that its Executive Vice President, Dr. Deepak Kotak, was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics/biel-videos/2515-ceolive-tv-interview-dr-deepak-kotak-vp-of-bioelectronics-corp-biel In the interview, Dr. … Continue Reading

BioElectronics’ ActiPatch® Actual-Use Survey Finds 90% Have Excellent Chronic Pain Management and 88% had a Decrease in Opioid Use

FREDERICK, MD, USA, February 4, 2015– BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released analysis of its ongoing and second long term follow up survey of customers in the United Kingdom and Ireland who are managing chronic pain with ActiPatch® Therapy, and reducing their dependence on systemic pain … Continue Reading

BioElectronics Announces B. Braun as the UK Distributor for Pain Device in Orthopaedics

BioElectronics Corporation, USA, today announced that B. Braun Medical Ltd is the exclusive UK distributor of the BioElectronic’s RecoveryRx® pain device in orthopaedics and trauma. RecoveryRx® is a micro medical device that treats acute and chronic musculoskeletal pain and decreases oedema. RecoveryRx® will be introduced in the B. Braun enhanced recovery surgical programs, particularly hip … Continue Reading

UK Fibromyalgia Sufferers Petition the National Health Service to Integrate and Pay for BioElectronics’ ActiPatch® Therapy

FREDERICK, MD, USA, November 26, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that Pifflers United Chronic and Invisible Illnesses Support Community, www.facebook.com/PifflersUnited, is petitioning the United Kingdom’s NHS’ National Institute for Health & Care Excellence (NICE) for new guidelines for effective Fibromyalgia pain management … Continue Reading

PIFFLERS UNITED – “SUPPORTING ANYONE LIVING WITH CHRONIC/INVISIBLE ILLNESS” REPORTS ACTIPATCH® BIOELECTRONIC THERAPY RELIEVES CHRONIC PAIN IN FIBROMYALGIA

Devon, United Kingdom – Pifflers United Chronic and Invisible Illnesses Support Community, www.facebook.com/PifflersUnited announced the release of results of a study of ActiPatch®, a new bioelectronic pain therapy device, in the self-management of fibromyalgia pain. The results demonstrated that when used in the area of worst pain, very significant clinically meaningful pain reduction can be … Continue Reading

BioElectronics Changing Chronic Pain Treatments

EVP Dr. Deepak Kotak to Address the OTC Pharma Asia Conference FREDERICK, MD, USA, November 5, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics’ innovative chronic pain therapy at the OTC … Continue Reading

Chronic Pain Sufferers Confirm BioElectronics’ ActiPatch® Therapy Provides Life Changing Pain Relief

FREDERICK, MD, USA, October 27, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. The data now includes responses from 856 consumers … Continue Reading

Facebook Survey Shows UK Consumers Experience 52% Reduction in Intractable Chronic Pain with ActiPatch® Therapy in Musculoskeletal Pain

FREDERICK, MD, USA, August 26, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released the updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. Overall results for chronic musculoskeletal pain showed … Continue Reading

BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live

Dr. Kotak Shares BioElectronics Opportunities in New Markets   FREDERICK, MD, USA, August 19, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices said that its EVP Dr. Deepak Kotak was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel In the … Continue Reading

BioElectronics President Letter to Shareholders

August 4, 2014 Dear BIEL Shareholders: BioElectronics Corporation’s mission is to change the way people heal and relieve their pain.  As the chart below, that clearly demonstrates that, we have done exactly that. Chronic pain sufferers in the United Kingdom said that ActiPatch reduced their pain by more than 50%.  This is what the BioElectronics … Continue Reading